Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Asset disposition
Quarterly results
Director comp.
Acq. announced
Director departure
Appointed director

ORE PHARMACEUTICAL HOLDINGS INC. (ORXE) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/11/2011 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/01/2010 SC 13D Steel Partners, Ltd. reports a 41.5% stake in Ore Pharmaceutical Holdings Inc.
09/24/2010 15-12G Form 15-12G - Securities registration termination [Section 12(g)]
08/11/2010 10-Q Quarterly Report for the period ended June 30, 2010
07/22/2010 8-K Quarterly results
05/11/2010 10-Q Quarterly Report for the period ended March 31, 2010
04/29/2010 10-K/A Annual Report for the period ended December 31, 2009 [amend]
04/19/2010 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
04/05/2010 25-NSE Form 25-NSE -
03/31/2010 10-K Annual Report for the period ended December 31, 2009
03/22/2010 8-K Form 8-K - Current report
02/12/2010 8-K Form 8-K - Current report
02/12/2010 SC 13G/A GENE LOGIC INC reports a 6.6% stake in ORE PHARMACEUTICAL HOLDINGS INC.
02/03/2010 8-K Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran...
Docs: "ORE PHARMACEUTICAL HOLDINGS INC."
11/16/2009 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans
11/16/2009 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
11/13/2009 10-Q Quarterly Report for the period ended September 30, 2009
11/13/2009 8-K Form 8-K - Current report
10/21/2009 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications t...
Docs: "Amended and Restated Bylaws of Ore Pharmaceuticals Inc",
"Ore Pharmaceuticals Announces Shareholder Approval of All Annual Meeting Proposals and Reorganization into a Holding Company Structure"
09/22/2009 ARS Form ARS - Annual Report to Security Holders
09/10/2009 425 Form 425 - Prospectuses and communications, business combinations
09/10/2009 8-K Other Events, Financial Statements and Exhibits
Docs: "Copy of electronic slides to accompany presentations starting on or about September 11, 2009"
09/09/2009 8-K Form 8-K - Current report
09/09/2009 425 Form 425 - Prospectuses and communications, business combinations
09/04/2009 EFFECT Form EFFECT -
09/02/2009 S-4/A Form S-4 - Registration of securities, business combinations [amend]
08/19/2009 8-K Form 8-K - Current report
08/19/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Item 5.02. Departure of Directors"
08/17/2009 425 Form 425 -- Prospectuses and communications, business combinations
08/17/2009 8-K Quarterly results
Docs: "Second Quarter 2009 Financial Results Reported"
08/14/2009 10-Q Quarterly Report for the period ended June 30, 2009
08/06/2009 8-K Termination of a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointmen...
Docs: "15",
"James W. Fordyce Named to Ore Pharmaceuticals Board of Directors"
07/27/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/21/2009 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Departure of Directors o...
Docs: "14",
"Benjamin L. Palleiko Named Chief Financial Officer of Ore Pharmaceuticals"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy